Is It Too Late to Start Myopia Control at 15?

Teenagers are a different practical problem from younger children. They handle their own lenses, they are largely past the fastest years of progression, and they care intensely about things no clinical guideline mentions. The honest answer to the question above is that fifteen is later than ideal and not too late, and the reasons are worth understanding before you decide.

On this page

Is It Too Late?

Is 15 too late to start myopia control?

No, but the calculus changes. Progression slows through the teens and settles in the early twenties, so a fifteen year old has less remaining growth to prevent than an eight year old. If measurements show they are still progressing, treatment still lowers where they end up. If they have been stable two years, the case is weaker.

The decision hinges on one thing: is this eye still growing? That is a measurement question, not an age question. A seventeen year old still gaining half a diopter a year has more to gain than a thirteen year old who has not moved in two years.

There is a second reason teenagers start, legitimate even when the control benefit is modest. A teenager who wants out of glasses for sport or appearance is choosing Ortho-K for the correction, with progression control as a bonus. That is fine, as long as everyone is clear which is driving the decision.

Compliance and Independence

Teenagers handle their own lenses, and there is no parent standing over the sink. What replaces supervision is a routine the teenager owns and a small number of non-negotiable rules.

Never tap water. Not on lenses, not in the case, not at a friend’s house, not once.
Never sleep in a lens that was not cleaned. A tired night is a reason to skip wear, not to skip the routine.
Lenses out and call us for a red, painful, light-sensitive, or discharging eye. Teenagers push through discomfort. Here that instinct causes harm.
Do not share, improvise, or stretch a solution bottle. Cheap corners get expensive.
Tell us the truth about wear. Missed nights do not annoy us. A chart assuming wear that did not happen misleads us.

Teenage compliance with Ortho-K tends to beat daytime soft lenses, because the routine is short, private, and attached to bedtime. The reward is also immediate and obvious, which is rare for a health behaviour at that age.

Sport, Screens, and Self-Image

These are the reasons teenagers agree to this, and they are not vanity.

Sport. No frames to break, no lens drying out mid-game, no goggles over glasses, nothing to lose at an away meet.
Appearance. A teenager who dislikes how they look in glasses finds ways not to wear them, which is worse for their vision than any lens choice. Removing that conflict is clinical, not cosmetic.
Long screen days. With nothing in the eye during the day, the end-of-day dryness that soft lenses produce does not arise.
Driving. We check the visual result holds through evening hours before signing off for a new driver.
Independence. Nothing in a bag or a locker, nothing to explain.

The athletic case in more detail is in Ortho-K for Athletes, and the teen-specific version of the lifestyle picture is in Ortho-K for Teens.

What We Ask of a Teenager

We talk to the teenager directly at the consultation, not only to the parent. If they are not interested the treatment will not be followed, and better to learn that in the chair than three months in.

Come willing to try. Not sold, just willing. Reluctance is fine. Refusal points to another option.
Learn the handling properly. Nothing is dispensed until insertion, removal, and cleaning are independent.
Wear consistently for the first month. A stop-start start makes the result look worse than it is.
Come to the follow-up visits. Short, and where problems get caught early.
Be honest about the routine. Including when it slips.

If Ortho-K is not the right fit, see Ortho-K vs Soft Contacts and Myopia Control.

Frequently Asked Questions

How do I know whether my sixteen year old is still progressing?

The prescription history is the first clue and axial length is the answer. If the prescription moved in either of the last two years, progression is likely ongoing. If not, biometry tells you whether the eye is growing under a prescription that has not yet stepped up.

Bring every past prescription you can find. Three or four points make the trajectory obvious.

What happens when they leave for college?

Ortho-K travels well. The kit is small, the routine is private, and nothing needs managing during the day. We schedule follow-up around term breaks and can coordinate with a practitioner near campus for anything urgent. See Long-Term Maintenance.

Should we just wait for LASIK at eighteen?

Surgery requires a stable prescription, which most people do not reach until their twenties, so waiting means more years in glasses and does nothing about progression meanwhile.

Ortho-K is reversible and does not close the surgical door. Some patients use it for years, then choose surgery as adults. See Ortho-K vs LASIK.

My teenager has an unreliable sleep schedule. Does that matter?

Somewhat. Most patients need roughly six to eight hours of wear for a full-day result, so a teenager sleeping four hours gets a partial result and notices vision fading in the afternoon.

Occasional short nights are manageable. A chronic pattern is worth raising at the consultation, because it changes what we can promise.

Can they wear eye makeup?

Yes. Because the lenses are worn only at night, makeup and lenses barely overlap. Remove makeup fully before insertion, with clean dry hands. This is a practical advantage over daytime lenses.

Is the cost different for a teenager?

The complete Ortho-K program starts at $1,800 at any age, with a candidacy consultation starting at $250 credited toward it. Where a teenager is still progressing, the ongoing myopia control program starts at $1,200 per year.

A stable teenager choosing Ortho-K purely for correction does not need the monitoring program. You receive your exact figure in writing before you commit. See Package Pricing.

Last updated August 23, 2026. Clinically reviewed by Dr. Mark Page.